Cargando…
Cardiac MRI in Fabry disease
Fabry disease is a rare, progressive X-linked inherited disorder of glycosphingolipid metabolism due to a deficiency of α-galactosidase A enzyme. It leads to the accumulation of globotriaosylceramide within lysosomes of multiple organs, predominantly the vascular, renal, cardiac, and nervous systems...
Autores principales: | Umer, Muhammad, Kalra, Dinesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931723/ https://www.ncbi.nlm.nih.gov/pubmed/36818911 http://dx.doi.org/10.3389/fcvm.2022.1075639 |
Ejemplares similares
-
Treatment of Fabry Disease: Established and Emerging Therapies
por: Umer, Muhammad, et al.
Publicado: (2023) -
Electrocardiographic Changes and Arrhythmia in Fabry Disease
por: Namdar, Mehdi
Publicado: (2016) -
Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Münster Study (FaMüS) data
por: Engelen, Markus A, et al.
Publicado: (2012) -
Importance of Echocardiography and Clinical “Red Flags” in Guiding Genetic Screening for Fabry Disease
por: Citro, Rodolfo, et al.
Publicado: (2022) -
Serum Biomarkers of Endothelial Dysfunction in Fabry Associated Cardiomyopathy
por: Loso, Jefferson, et al.
Publicado: (2018)